Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Acotiamide is a prokinetic, currently approved for use in Japan and India for FD.
Acotiamide is a recently developed Cholinesterase inhibitor that also exerts a presynaptic muscarinic autoreceptor inhibitory activity. It was shown to enhance both contractile and accommodation activities of the stomach and, interestingly, to improve dyspeptic symptoms suggestive of gastroparesis, but not epigastric pain and burning symptoms
Ma…